A proof‐of‐concept, phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug
| Autor principal: | |
|---|---|
| Formato: | article |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | https://doi.org/10.1111/bph.14641 |
| País: | Brasil |
| Oai: | 002991891 |